Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study. (2021)

First Author: Milojkovic D


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 32449159

Publication URI:

Type: Journal Article/Review

Volume: 192

Parent Publication: British journal of haematology

Issue: 1

ISSN: 0007-1048